Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenesis, Pharmacia Pen Drug-Discovery Collaboration

NEW YORK, July 30 - NeoGenesis Pharmaceuticals said today it will apply its NeoMorph compound library and ALIS ligand-identification technology in a drug-discovery deal with Pharmacia.

 

The deal calls for NeoGenesis to use NeoMorph and ALIS on certain proteins supplied by Pharmacia in the hopes of discovering small-molecule compounds that bind to them.

 

In exchange, NeoGenesis, of Cambridge, Mass., will receive undisclosed upfront payments, milestones, and royalties pegged to the success of the collaboration.

 

NeoGenesis said Pharmacia will oversee the management of any drug leads that arise from the research.

 

Click here or more information.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.